HB 1424 (2020): allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“HB 1424 (2020): allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.” Granite Record, https://graniterecord.org/bill/2020/hb1424. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). HB 1424 (2020): allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb1424
Chicago
Granite Record. “HB 1424 (2020): allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb1424.
BibTeX
@misc{bill-2020-hb1424, title = {HB 1424 (2020): allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb1424}, note = {Accessed 24 Oct. 2026} }

HB 1424 (2020)

allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

  • Status: Died on the table
  • Term: 2019-2020
  • House committee: Health, Human Services and Elderly Affairs
  • Subject: Public and Mental Health

The Story

It was introduced on January 8, 2020 and referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on January 29, 2020. The committee held a work session on February 12, 2020. The committee met in executive session on February 13, 2020 to vote on its recommendation. The committee held a work session on February 18, 2020. The committee met in executive session on February 18, 2020 to vote on its recommendation. The committee voted 19–1 to recommend that the House pass it with changes (amendment 2020-0630h), and the report was placed on the consent calendar. The committee's amendment (2020-0630h) was adopted on a voice vote on March 11, 2020, changing the text of the bill. On March 11, 2020 the House voted to pass it with changes on a voice vote. On June 16, 2020 the Senate adopted “Introduced 06/16/2020, and Laid on Table” on a voice vote. The bill died on the table under Senate Rule 3-23 at adjournment on September 16, 2020, having been set aside and never taken back up.

Sponsors

Hearings and Sessions

  • January 29, 2020, 11:00 AM: public hearing, House Health, Human Services and Elderly Affairs, LOB 205
  • February 12, 2020, 10:00 AM: subcommittee work session, House Health, Human Services and Elderly Affairs, LOB 104
  • February 13, 2020, 11:00 AM: executive session, House Health, Human Services and Elderly Affairs, LOB 205
  • February 18, 2020, 10:00 AM: subcommittee work session, House Health, Human Services and Elderly Affairs, LOB 209
  • February 18, 2020, 1:00 PM: executive session, House Health, Human Services and Elderly Affairs, LOB 205

Votes

  • March 11, 2020, House: Ought to Pass with Amendment 2020-0630h (NT) — voice vote, passed
  • June 16, 2020, Senate: Introduced 06/16/2020, and Laid on Table — voice vote, passed

The Docket

  • January 8, 2020: Introduced 01/08/2020 and referred to Health, Human Services and Elderly Affairs
  • January 29, 2020: Public Hearing: 01/29/2020 11:00 am LOB 205
  • February 12, 2020: Subcommittee Work Session: 02/12/2020 10:00 am LOB 104
  • February 13, 2020: Executive Session: 02/13/2020 11:00 am LOB 205
  • February 18, 2020: Subcommittee Work Session: 02/18/2020 10:00 am LOB 209 (if not exec'd on the 13th)
  • February 18, 2020: Executive Session: 02/18/2020 01:00 pm LOB 205 (if not exec'd on the 13th)
  • March 11, 2020: Committee Report: Ought to Pass with Amendment #2020-0630h (NT) for 03/11/2020 (Vote 19-1; CC)
  • March 11, 2020: Amendment #2020-0630h (NT): AA VV 03/11/2020
  • March 11, 2020: Ought to Pass with Amendment 2020-0630h (NT): MA VV 03/11/2020
  • June 16, 2020: Introduced 06/16/2020, and Laid on Table, MA, VV; 06/16/2020
  • September 16, 2020: Inexpedient to Legislate, Senate Rule 3-23, Adjournment 09/16/2020

Laws It Would Change

Related Bills

  • HB 90 (2021): allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

From the General Court